Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 67.9%

Gross margin was 67.9% in Q1 FY2026, down 8.2 pp from a year earlier. On a trailing-twelve-month basis it was 74.5%, up 2.6 pp year over year. Over 3 fiscal years it narrowed by 14.9 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
67.9%+1.5 pp QoQ
Last fiscal yearDec 2025
65.8%-6.5 pp YoY
LTMMar 2026
74.5%+2.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.2 pp——
1 year-6.5 pp——
3 years-14.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
65.8%
Year-over-year change
-6.5pp

Gross Margin vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • CPH.TO's LTM Mar 2026 gross margin of 74.5% is the 2nd highest of the 8 companies compared; the peer median is 31.5%.
  • Its year-over-year change of +2.6 pp is the highest of 8, against a peer median of -7.6 pp.
  • Over three fiscal years its change of -14.9 pp compares with a peer median of -1.2 pp.
CPH.TO Competitors Peer median
Gross Margin for CPH.TO and competitors
Company Period LTM level YoY 3-year change
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202692.2% +1.9 pp-2.8 pp
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202674.5% +2.6 pp-14.9 pp
TSND.TOTerrAscend Corp.LTM Mar 202650.9% -0.7 pp+0.4 pp
GUD.TOKnight Therapeutics Inc.LTM Mar 202637.3% -7.6 pp-13.5 pp
ACB.TOAurora Cannabis Inc.LTM Mar 202631.5% -23.2 pp+32.8 pp
WEED.TOCanopy Growth CorporationLTM Mar 202623.6% -5.9 pp+54.0 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-3.1% -35.8 pp—
EDT.TOSpectral Medical Inc.LTM Mar 2026-79.2% -128.4 pp-270.1 pp
Peer median (excluding CPH.TO) 31.5%-7.6 pp-1.2 pp

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue21.94M20.68M21.16M33.36M51.33M
Cost of Revenue3.68M3.99M4.07M9.26M17.56M
Gross Profit18.26M16.68M17.09M24.1M33.77M
Gross Margin83.2%80.7%80.8%72.2%65.8%
Research & Development88K98K139K021.37K
Selling, General & Admin5.11M4.4M5.43M12.24M16.3M
Operating Expenses6.45M5.63M5.56M16.26M16.97M
Depreciation & Amortization701K989K1.23M4.02M7.23M
EBITDA13.66M12.04M11.53M11.87M24.1M
EBITDA Margin62.2%58.2%54.5%35.6%46.9%
Operating Income11.82M12.04M11.53M7.85M16.8M
Operating Margin53.9%58.2%54.5%23.5%32.7%
Interest Income12K464K1.87M330K0
Interest Expense92K0001.19M
Other Income / Expenses(2M)(560K)1.15M(4.89M)661.38K
Income Before Tax11.06M11.48M12.68M2.96M17.46M
Pre-Tax Margin50.4%55.5%59.9%8.9%34.0%
Income Tax Expense3.3M(15.16M)(7.7M)(8.59M)(10.34M)
Net Income7.76M26.64M20.38M11.55M27.81M
Net Margin35.4%128.8%96.3%34.6%54.2%
EPS (Basic)0.291.060.800.471.09
EPS (Diluted)0.291.040.800.471.07
Weighted Avg Shares26.6M25.13M25.48M24.72M25.48M
Weighted Avg Shares (Diluted)26.83M25.59M25.42M24.57M25.99M

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.